Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Equity Average (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Equity Average data on record, last reported at $51.3 million in Q3 2025.

  • For Q3 2025, Equity Average rose 475.21% year-over-year to $51.3 million; the TTM value through Sep 2025 reached $51.3 million, up 475.21%, while the annual FY2024 figure was -$28500.0, 100.11% down from the prior year.
  • Equity Average reached $51.3 million in Q3 2025 per FBIO's latest filing, up from $34.9 million in the prior quarter.
  • Across five years, Equity Average topped out at $246.3 million in Q2 2021 and bottomed at -$14.6 million in Q3 2023.
  • Average Equity Average over 5 years is $83.4 million, with a median of $34.9 million recorded in 2025.
  • Peak YoY movement for Equity Average: crashed 579.81% in 2024, then soared 1412.43% in 2025.
  • A 5-year view of Equity Average shows it stood at $219.2 million in 2021, then crashed by 65.47% to $75.7 million in 2022, then plummeted by 107.7% to -$5.8 million in 2023, then fell by 23.39% to -$7.2 million in 2024, then surged by 813.17% to $51.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $51.3 million in Q3 2025, $34.9 million in Q2 2025, and $15.4 million in Q1 2025.